HomeVenture Capital

Venture Capital

Biotech

Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis

Life Sciences Times - August 18, 2026

Venture Capital

InduPro Raises $77 Million, Doses First Patient in Phase 1 Trial of Lead Cancer Therapy

Life Sciences Times - August 12, 2026

Biotech

Expedition Therapeutics Raises $115 Million, Begins Phase 2 COPD Trial

Life Sciences Times - August 5, 2026

Pharma

Apnimed Prices Upsized IPO at $16 Per Share, Raising $192 Million

Life Sciences Times - August 3, 2026

Venture Capital

Dash Bio Raises $30 Million Series A to Speed Drug Development

Life Sciences Times - August 3, 2026

Biotech

Adjuvia Therapeutics Raises $8 Million to Advance Mitochondrial Disease Drug

Life Sciences Times - July 29, 2026 0

Biotech

CORE Biomedicine Raises $21 Million to Advance Precision Cancer Therapies

Life Sciences Times - July 28, 2026 0

Venture Capital

AdvanCell Raises $315 Million to Advance Targeted Alpha Cancer Therapies

Life Sciences Times - July 15, 2026 0

Venture Capital

Draig Therapeutics Raises $65 Million to Advance Neuropsychiatric Drug Pipeline

Life Sciences Times - July 14, 2026 0

Venture Capital

Pediatrica Health Group Raises $28 Million to Expand Pediatric Primary Care

Life Sciences Times - July 7, 2026 0

Venture Capital

Novartis to Acquire Sofinnova-Backed Myricx Bio in Deal Worth Up to $1.5 Billion

Life Sciences Times - July 6, 2026 0

Medtech

Anodyne Nanotech Raises $12.6 Million to Advance Weekly GLP-1 Patch

Life Sciences Times - June 24, 2026 0

Venture Capital

CroíValve Raises Additional $27 Million to Expand DUO Adapt Study

Life Sciences Times - June 23, 2026 0

Venture Capital

Rejoni Secures $25 Million to Advance Juveena Hydrogel System Toward FDA Approval

Life Sciences Times - June 16, 2026 0

Venture Capital

SonoThera Raises $125 Million to Advance Nonviral Genetic Medicine Programs

Life Sciences Times - June 11, 2026 0

Venture Capital

QT Imaging Prices $10 Million Public Offering

Life Sciences Times - May 15, 2026 0

Biotech

CellCentric Raises $220 Million to Advance Multiple Myeloma Drug Trials

Life Sciences Times - May 6, 2026 0

12 3...114 Page 1 of 114

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

September 1, 2026

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

September 1, 2026

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

September 1, 2026

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

September 1, 2026

Venture Capital

Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis

InduPro Raises $77 Million, Doses First Patient in Phase 1 Trial of Lead Cancer Therapy

Expedition Therapeutics Raises $115 Million, Begins Phase 2 COPD Trial

Apnimed Prices Upsized IPO at $16 Per Share, Raising $192 Million

Dash Bio Raises $30 Million Series A to Speed Drug Development

Most Read

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

EDITOR PICKS

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

THIS WEEK'S STORIES

Philips Korea, HoneyNaps Partner on Sleep and Cardiovascular Health

Lilly Reports One-Year Phase 3b Data for Taltz and Zepbound in Psoriatic Disease and Obesity

Wisner Baum Attorneys Named to Leadership Roles in Boston Scientific Spinal Cord Stimulator Litigation

POPULAR CATEGORY

ABOUT US

FOLLOW US